Biosensors International

Last updated
Biosensors International Group, Ltd.
Company typePublic (SGX: B20 )
Industry Medical technology
Foundedunknown
HeadquartersSingapore
Key people
Lu Yoh-Chie, Chairman and founding CEO; Mike Kleine, CEO
Products Medical devices
RevenueUSD $37.8 Million (2006)
Website www.biosensors.com

Biosensors InternationalGroup, Ltd. is a medical device company that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The company was listed on the mainboard of the Singapore Exchange (SGX) in May 2005.

Contents

The global headquarters of the company is located in Singapore and holds the main manufacturing facilities and research and development centers. The European headquarters are in Morges, Switzerland. The Swiss office is also the legal manufacturer of BioMatrix, the company's current leading product. Biosensors International also licenses its proprietary drug-eluting stent technologies to other medical device companies and specialty stent providers, including Terumo, Devax, Inc., and Xtent, Inc.

Biosensors International Group has a joint-venture in Hong Kong listed as Shandong Weigao to market and distribute coronary stents in China. [1]

BioMatrix

BioMatrix is a drug-eluting stent that utilizes proprietary technologies of Biosensors International:

Biosensors obtained approval for this drug-eluting stent product in January 2008.

See also

Notes

  1. Unknown.Biosensors and Weigao Sign Letter of Intent and Expand Business Collaboration [ permanent dead link ], Biosensors Investor Relations
  2. Yazdani, Saami; Vorpahl, Marc; Nakano, Masataka; Su, Shih-Horng; Kolodgie, Frank; Virmani, Renu. "In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent". eurointervention.pcronline.com. Retrieved 2025-02-14.
  3. CA2705764A1,Vecerina, Ivan&Pham, Vinh,"Automated stent coating apparatus and method",issued 2009-05-22